Synapse - Works

Results (13087)

Impact of busulphan exposure on transplant outcomes for patients with advanced myelodysplastic syndromes undergoing CD34 selected allogeneic hematopoietic cell transplantation

Meeting Abstract

Tamari, R.; Proli, A.; Zheng, J. T.; Jakubowski, A. A.; Papadopoulos, E. B.; Ponce, D. M.; Devlin, S.; Sauter, C. S.; Young, J. W.; Giralt, S. A.; more...
Blood (2015)

Fulltext@MSK | Save

Reduced emergency room utilization for initiation of anticoagulation with rivaroxaban versus Low Molecular Weight Heparin for treatment of cancer-associated thrombosis

Meeting Abstract

Soff, A. P.; Dong, J.; Dong, A.; Devlin, S.; Mantha, S.; Parameswaran, R.; Soff, G. A.
Blood (2015)

Fulltext@MSK | Save

A phase 1 study of the DOT1L inhibitor, pinometostat (EPZ-5676), in adults with relapsed or refractory leukemia: Safety, clinical activity, exposure and target inhibition

Meeting Abstract

Stein, E. M.; Garcia-Manero, G.; Rizzieri, D. A.; Tibes, R.; Berdeja, J. G.; Jongen-Lavrencic, M.; Altman, J. K.; Dohner, H.; Thomson, B.; Blakemore, S. J.; more...
Blood (2015)

Fulltext@MSK | Save

Updated efficacy and safety data from the AETHERA trial of consolidation with brentuximab vedotin after autologous stem cell transplant (ASCT) in Hodgkin lymphoma patients at high risk of relapse

Meeting Abstract

Sweetenham, J.; Walewski, J.; Nademanee, A. P.; Masszi, T.; Agura, E.; Holowiecki, J.; Abidi, M. H.; Chen, A. I.; Stiff, P.; Viviani, S.; more...
Blood (2015)

Fulltext@MSK | Save

Targeting CD99 in T-cell neoplasms with monoclonal antibodies

Meeting Abstract

Tavakkoli, M.; Lee, D. H.; Durham, B.; Chung, S. S.; Park, C. Y.
Blood (2015)

Fulltext@MSK | Save

Veliparib (ABT-888), bendamustine, and rituximab (VBR) is well tolerated and efficacious in patients with lymphoma: Final analysis of a phase 1b clinical trial of VB and a cohort expansion of VBR in patients with B-cell lymphoma

Meeting Abstract

Soumerai, J. D.; Zelenetz, A. D.; Moskowitz, C. H.; Younes, A.; Palomba, M. L.; Hamlin, P. A. Jr; Noy, A.; Horwitz, S. M.; Matasar, M. J.; Moskowitz, A. J.; more...
Blood (2015)

Fulltext@MSK | Save

Safety and clinical activity of atezolizumab (anti-PDL1) in combination with obinutuzumab in patients with relapsed or refractory non-Hodgkin lymphoma

Meeting Abstract

Till, B. G.; Park, S. I.; Popplewell, L. L.; Goy, A.; Penuel, E.; Venstrom, J. M.; Liu, B.; Fingerle-Rowson, G.; Byon, J.; Woodard, P.; more...
Blood (2015)

Fulltext@MSK | Save

Autologous hematopoietic stem cell transplantation overcomes primary refractory disease in multiple myeloma patients treated with novel agents

Meeting Abstract

Shah, G. L.; Hsu, M.; Devlin, S.; Chung, D. J.; Hassoun, H.; Koehne, G.; Korde, N. S.; Lendvai, N.; Lesokhin, A. M.; Landgren, O.; more...
Blood (2015)

Fulltext@MSK | Save

Long-term follow up of pediatric patients with Hodgkin lymphoma treated with high dose therapy and autologous stem cell transplantation

Meeting Abstract

Roth, L. G.; O'Donohue, T.; Trippett, T.; Klein, E.; Kernan, N. A.; Kobos, R.; Prockop, S.; Scaradavou, A.; Shukla, N.; Steinherz, P. G.; more...
Blood (2015)

Fulltext@MSK | Save

A detailed evaluation of transplant-related toxicities and outcome for patients with CNS lymphoma (CNSL) consolidated with high-dose therapy and autologous stem cell transplantation (HDT-ASCT) using thiotepa, busulfan (Bu), cyclophosphamide (TBC) conditioning

Meeting Abstract

Scordo, M.; Bhatt, V.; Hsu, M.; Omuro, A. M.; Matasar, M. J.; DeAngelis, L.; Dahi, P. B.; Moskowitz, C. H.; Giralt, S. A.; Sauter, C. S.
Blood (2015)

Fulltext@MSK | Save